by sagarp4412@gmail.com | Nov 16, 2026 | Analytics
Medical device companies cannot measure commercial success through sales figures alone. A hospital purchasing a surgical navigation system does not guarantee that surgeons will adopt it, that the equipment will be used regularly, or that the installation will generate...
by sagarp4412@gmail.com | Nov 16, 2026 | Analytics
Oncology commercialization depends on understanding three interconnected aspects of the healthcare ecosystem: who treats patients, what treatments patients receive, and where clinical research takes place. Yet pharmaceutical companies often analyze these activities...
by sagarp4412@gmail.com | Nov 16, 2026 | Pharma
A specialty drug launch can generate strong prescription demand and still fall short of its commercial objectives. The reason is often hidden between prescription and treatment initiation.A physician may prescribe a therapy, but the patient might be waiting for...
by sagarp4412@gmail.com | Nov 16, 2026 | Analytics
Commercial analytics for cell and gene therapy (CGT) uses patient, physician, treatment-center, claims, and access data to show how many patients can realistically be identified, referred, and treated after launch. It matters because an approved CGT can still struggle...
Recent Comments